Venture Capital
Now Fully Financed, Okyanos Is Poised To Start Mending Broken Hearts
Following its $8.9 million Series B capital raise in March, Okyanos Heart Institute is rapidly approaching the day when it will be able to treat the first heart patient using autologous adipose derived regenerative cells (ADRCs) in the Bahamas. Adipose, or fat, is the richest source of regenerative cells in the body and the term "autologous" simply means that the cells are derived from the same patient undergoing the cell therapy treatment.
Exclusive: SoftBank Capital closes in on financing round with Kony - sources
SoftBank Corp's venture capital arm is close to securing an investment in enterprise mobile company Kony Inc, and could announce a deal as soon as Tuesday, people close to the matter said.
Zenefits raises $66.5 million in accelerating cycle for venture capitalists
Business startup Zenefits has raised another $66.5 million from investors, months after its first capital-raising, following a pattern set previously by a handful of hot, young consumer companies that proved their worth to investors over a short span.
Salesforce-backed Anaplan raises $100 million
Performance-management company Anaplan has raised $100 million in fresh capital, it said Tuesday, joining a growing roster of enterprise companies winning private funding even as that sector wilts in the public markets.